Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2003

01-08-2003 | Original Article

Rapid normalization of osseous FDG uptake following traumatic or surgical fractures

Authors: Hongming Zhuang, Joseph W. Sam, Thomas K. Chacko, Paulo S. Duarte, Marc Hickeson, Qi Feng, Kozaim Z. Nakhoda, Liang Guan, Phillip Reich, Shirley M. Altimari, Abass Alavi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2003

Login to get access

Abstract

It is known that following a traumatic fracture or surgical intervention, bone scintigraphy reveals positive results for an extended period of time, posing a challenge when evaluating patients for possible malignancy or superimposed osteomyelitis. Previous reports indicate that acute fractures can also result in increased fluorine-18 fluorodeoxyglucose (FDG) accumulation and therefore cause difficulties when patients are evaluated for other indications by FDG-PET. The purpose of this study was to assess the pattern and time course of abnormal FDG uptake following traumatic or surgical fracture. A total of 1,517 consecutive patients who underwent whole-body FDG-PET imaging were retrospectively studied. A history of fractures or orthopedic intervention was obtained from an interview prior to scanning. The FDG-PET results were compared with the results of other imaging studies, including bone scans, radiographs, CT, and MRI, as well as surgical pathology reports. Thirty-seven patients with a known date of traumatic or surgical fracture were identified. Among these, 14 had fractures or surgery within 3 months prior to FDG-PET, while 23 had fractures or surgical intervention greater than 3 months prior to FDG-PET. FDG-PET showed no abnormally increased uptake at the known fracture or surgical sites in 30 of these patients. Notably, in the 23 patients with fractures more than 3 months old, all but one showed no abnormally increased uptake. Furthermore, the positive FDG uptake in this exception was a result of complicating osteomyelitis. In the 14 patients with a history of fracture less than 3 months old, only six had abnormally increased FDG uptake. Following traumatic or surgical fractures, FDG uptake is expected to be normal within 3 months unless the process is complicated by infection or malignancy.
Literature
1.
go back to reference Matin P. Appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 1979; 20:1227–1231. Matin P. Appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 1979; 20:1227–1231.
2.
go back to reference Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.PubMed Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.PubMed
3.
go back to reference Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.PubMed Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.PubMed
4.
go back to reference Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998; 91:3340–3346.PubMed Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998; 91:3340–3346.PubMed
5.
go back to reference Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145–2152.PubMed Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145–2152.PubMed
6.
go back to reference Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281–284.PubMed Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281–284.PubMed
7.
go back to reference Schmitz A, Risse HJ, Kalicke T, Grunwald F, Schmitt O. FDG-PET for diagnosis and follow-up of inflammatory processes: first results from an orthopedic view. Z Orthop Grenzg 2000; 138:407–412.CrossRef Schmitz A, Risse HJ, Kalicke T, Grunwald F, Schmitt O. FDG-PET for diagnosis and follow-up of inflammatory processes: first results from an orthopedic view. Z Orthop Grenzg 2000; 138:407–412.CrossRef
8.
go back to reference Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42:44–48.PubMed Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42:44–48.PubMed
9.
go back to reference Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H and Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27:1305–1311.PubMed Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H and Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27:1305–1311.PubMed
10.
go back to reference Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999; 40:1407.PubMed Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999; 40:1407.PubMed
11.
go back to reference Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19:13–14.PubMed Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19:13–14.PubMed
12.
go back to reference Karp JS, Muehllehner G, Qu H, Yan XH. Singles transmission in volume-imaging PET with a137Cs source. Phys Med Biol 1995; 40:929–944.PubMed Karp JS, Muehllehner G, Qu H, Yan XH. Singles transmission in volume-imaging PET with a137Cs source. Phys Med Biol 1995; 40:929–944.PubMed
13.
go back to reference Bedigian MP, Benard F, Smith RJ, Karp JS, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25:659–661.PubMed Bedigian MP, Benard F, Smith RJ, Karp JS, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25:659–661.PubMed
14.
go back to reference Ma LD, Frassica FJ, Bluemke DA, Fishman EK. CT and MRI evaluation of musculoskeletal infection. Crit Rev Diagn Imaging 1997; 38:535–568.PubMed Ma LD, Frassica FJ, Bluemke DA, Fishman EK. CT and MRI evaluation of musculoskeletal infection. Crit Rev Diagn Imaging 1997; 38:535–568.PubMed
15.
go back to reference Seabold JE, Nepola JV. Imaging techniques for evaluation of postoperative orthopedic infections. Q J Nucl Med 1999; 43:21–28.PubMed Seabold JE, Nepola JV. Imaging techniques for evaluation of postoperative orthopedic infections. Q J Nucl Med 1999; 43:21–28.PubMed
16.
go back to reference Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524–528.PubMed Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524–528.PubMed
17.
go back to reference Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose—its potential in differentiating between stress-fracture and neoplasia. Clin Nucl Med 1989; 14:906–908.PubMed Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose—its potential in differentiating between stress-fracture and neoplasia. Clin Nucl Med 1989; 14:906–908.PubMed
18.
go back to reference Schmitz A, Risse JH, Textor J, Zander D, Biersack HJ, Palmedo H. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis Int 2002; 13:755–761.CrossRef Schmitz A, Risse JH, Textor J, Zander D, Biersack HJ, Palmedo H. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis Int 2002; 13:755–761.CrossRef
19.
go back to reference De Winter F, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83:651–660. De Winter F, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83:651–660.
20.
go back to reference Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244–1247.CrossRefPubMed Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244–1247.CrossRefPubMed
21.
go back to reference Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 2002; 49:267–271.PubMed Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 2002; 49:267–271.PubMed
22.
go back to reference Wu HC, Yen RF, Shen YY, Kao CH, Lin CC and Lee CC. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients wih renal cell carcinomas—a preliminary report. J Cancer Res Clin Oncol 2002; 128:503–506.CrossRefPubMed Wu HC, Yen RF, Shen YY, Kao CH, Lin CC and Lee CC. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients wih renal cell carcinomas—a preliminary report. J Cancer Res Clin Oncol 2002; 128:503–506.CrossRefPubMed
23.
go back to reference Charkes ND. Skeletal blood flow—Implications for bone scan interpretation. J Nucl Med 1980; 21:91–98.PubMed Charkes ND. Skeletal blood flow—Implications for bone scan interpretation. J Nucl Med 1980; 21:91–98.PubMed
Metadata
Title
Rapid normalization of osseous FDG uptake following traumatic or surgical fractures
Authors
Hongming Zhuang
Joseph W. Sam
Thomas K. Chacko
Paulo S. Duarte
Marc Hickeson
Qi Feng
Kozaim Z. Nakhoda
Liang Guan
Phillip Reich
Shirley M. Altimari
Abass Alavi
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2003
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1198-x

Other articles of this Issue 8/2003

European Journal of Nuclear Medicine and Molecular Imaging 8/2003 Go to the issue

Image of the Month

Situs inversus completus